Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer - No Study Results Posted

Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer (NSCLC)

This study has been terminated.

( See termination reason in detailed description. )

Study NCT00673049 Information provided by Pfizer

First Received: May 5, 2008 Last Updated: April 16, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	April 2012
Primary Completion Date:	March 2011 (Final data collection date for primary outcome measure)
Certification - "Seeking Initial Approval":	Submission Date: April 22, 2011